<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37465678</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Comprehensive bioinformatics analysis reveals the crosstalk genes and immune relationship between the systemic lupus erythematosus and venous thromboembolism.</ArticleTitle><Pagination><StartPage>1196064</StartPage><MedlinePgn>1196064</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1196064</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1196064</ELocationID><Abstract><AbstractText Label="BACKGROUND">It is well known that patients with systemic lupus erythematosus (SLE) had a high risk of venous thromboembolism (VTE). This study aimed to identify the crosstalk genes between SLE and VTE and explored their clinical value and molecular mechanism initially.</AbstractText><AbstractText Label="METHODS">We downloaded microarray datasets of SLE and VTE from the Gene Expression Omnibus (GEO) dataset. Differential expression analysis was applied to identify the crosstalk genes (CGs). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed on the shared genes. The shared diagnostic biomarkers of the two diseases were further screened from CGs using least absolute shrinkage and selection operator (Lasso) regression. Two risk scores for SLE and VTE were constructed separately to predict the likelihood of illness according to the diagnostic biomarkers using a logical regression algorithm. The immune infiltration levels of SEL and VTE were estimated <i>via</i> the CIBERSORT algorithm and the relationship of CGs with immune cell infiltration was investigated. Finally, we explored potential phenotype subgroups in SLE and VTE based on the expression level of CGs through the consensus clustering method and studied immune cell infiltration in different subtypes.</AbstractText><AbstractText Label="RESULT">A total of 171 CGs were obtained by the intersection of differentially expressed genes (DEGs) between SLE and VTE cohorts. The functional enrichment shown these CGs were mainly related to immune pathways. After screening by lasso regression, we found that three hub CGs (RSAD2, HSP90AB1, and FPR2) were the optimal shared diagnostic biomarkers for SLE and VTE. Based on the expression level of RSAD2 and HSP90AB1, two risk prediction models for SLE and VTE were built by multifactor logistic regression and systemically validated in internal and external validation datasets. The immune infiltration results revealed that CGs were highly correlated with multiple infiltrated immunocytes. Consensus clustering was used to respectively regroup SLE and VTE patients into C1 and C2 clusters based on the CGs expression profile. The levels of immune cell infiltration and immune activation were higher in C1 than in C2 subtypes.</AbstractText><AbstractText Label="CONCLUSION">In our study, we further screen out diagnostic biomarkers from crosstalk genes SLE and VTE and built two risk scores. Our findings reveal a close relationship between CGs and the immune microenvironment of diseases. This provides clues for further exploring the common mechanism and interaction between the two diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Yu, Yang, He, Zhang and Xu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jingfan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery and Intervention, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Qifan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhixuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery and Intervention, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guoxiong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery and Intervention, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054556" MajorTopicYN="Y">Venous Thromboembolism</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bioinformatics analysis</Keyword><Keyword MajorTopicYN="N">immune cells infiltration</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword><Keyword MajorTopicYN="N">unsupervised clustering</Keyword><Keyword MajorTopicYN="N">venous thromboembolism</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>4</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37465678</ArticleId><ArticleId IdType="pmc">PMC10350530</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1196064</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tunnicliffe DJ, Singh-Grewal D, Kim S, Craig JC, Tong A. Diagnosis, monitoring, and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines. Arthritis Care Res (Hoboken) (2015) 67(10):1440&#x2013;52. doi:&#xa0;10.1002/acr.22591</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22591</ArticleId><ArticleId IdType="pubmed">25778500</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood (2004) 104(1):143&#x2013;8. doi:&#xa0;10.1182/blood-2003-11-4085</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-11-4085</ArticleId><ArticleId IdType="pubmed">15026314</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang ER, Pineau CA, Bernatsky S, Neville C, Clarke AE, Fortin PR. Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus. J Rheumatol (2006) 33(9):1780&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16832849</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Diaz J, Garcia-Sosa I, Sanchez-Guerrero J. Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. J Rheumatol (2009) 36(1):68&#x2013;75. doi:&#xa0;10.3899/jrheum.071244</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.071244</ArticleId><ArticleId IdType="pubmed">19012362</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta BM, Kiani AN, Chen C, Jani J, Kickler TS, Petri M. Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus. Am J Hematol (2010) 85(1):83&#x2013;5. doi:&#xa0;10.1002/ajh.21566</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.21566</ArticleId><ArticleId IdType="pubmed">20029948</ArticleId></ArticleIdList></Reference><Reference><Citation>Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol (2011) 86(2):217&#x2013;20. doi:&#xa0;10.1002/ajh.21917</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.21917</ArticleId><ArticleId IdType="pubmed">21264912</ArticleId></ArticleIdList></Reference><Reference><Citation>Colling ME, Tourdot BE, Kanthi Y. Inflammation, infection and venous thromboembolism. Circ Res (2021) 128(12):2017&#x2013;36. doi:&#xa0;10.1161/CIRCRESAHA.121.318225</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318225</ArticleId><ArticleId IdType="pmc">PMC8202069</ArticleId><ArticleId IdType="pubmed">34110909</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard J, Yi ES. Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. Hum Pathol (2007) 38(6):871&#x2013;7. doi:&#xa0;10.1016/j.humpath.2006.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2006.11.017</ArticleId><ArticleId IdType="pubmed">17350667</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng KB, Wang LM, Gao HJ, Hu Y. [An study on screening the gene clusters associated with pulmonary embolism-deep venous thrombosis by oligo microarray]. Zhonghua Yi Xue Za Zhi (2007) 87(34):2420&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">18036322</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmon CT, Esmon NL. The link between vascular features and thrombosis. Annu Rev Physiol (2011) 73:503&#x2013;14. doi:&#xa0;10.1146/annurev-physiol-012110-142300</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-012110-142300</ArticleId><ArticleId IdType="pubmed">20887194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez GA, Efthymiou M, Isenberg DA, Cohen H. Under crossfire: thromboembolic risk in systemic lupus erythematosus. Rheumatol (Oxford) (2019) 58(6):940&#x2013;52. doi:&#xa0;10.1093/rheumatology/key307</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/key307</ArticleId><ArticleId IdType="pubmed">30380105</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, et al. . Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost (2014) 12(12):2074&#x2013;88. doi:&#xa0;10.1111/jth.12710</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12710</ArticleId><ArticleId IdType="pubmed">25163512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambas K, Chrysanthopoulou A, Vassilopoulos D, Apostolidou E, Skendros P, Girod A, et al. . Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis (2014) 73(10):1854&#x2013;63. doi:&#xa0;10.1136/annrheumdis-2013-203430</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203430</ArticleId><ArticleId IdType="pubmed">23873874</ArticleId></ArticleIdList></Reference><Reference><Citation>Palatinus A, Adams M. Thrombosis in systemic lupus erythematosus. Semin Thromb Hemost (2009) 35(7):621&#x2013;9. doi:&#xa0;10.1055/s-0029-1242716</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1242716</ArticleId><ArticleId IdType="pubmed">20013529</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. . NCBI GEO: archive for functional genomics data sets&#x2013;update. Nucleic Acids Res (2013) 41(Database issue):D991&#x2013;5. doi:&#xa0;10.1093/nar/gks1193</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1193</ArticleId><ArticleId IdType="pmc">PMC3531084</ArticleId><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Law CW, Chen YS, Shi W, Smyth GK. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol (2014) 15:(2). doi: 10.1186/gb-2014-15-2-r29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2014-15-2-r29</ArticleId><ArticleId IdType="pmc">PMC4053721</ArticleId><ArticleId IdType="pubmed">24485249</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, He QY. clusterProfiler: an r package for comparing biological themes among gene clusters. OMICS (2012) 16(5):284&#x2013;7. doi:&#xa0;10.1089/omi.2011.0118</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf (2013) 14:7. doi:&#xa0;10.1186/1471-2105-14-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-7</ArticleId><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U.S.A. (2005) 102(43):15545&#x2013;50. doi:&#xa0;10.1073/pnas.0506580102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw (2010) 33(1):1&#x2013;22. doi: 10.18637/jss.v033.i01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v033.i01</ArticleId><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. . The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res (2021) 49(D1):D605&#x2013;12. doi:&#xa0;10.1093/nar/gkaa1074</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 13(11):2498&#x2013;504. doi:&#xa0;10.1101/gr.1239303</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol (2014) 8 Suppl 4:S11. doi:&#xa0;10.1186/1752-0509-8-S4-S11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods (2015) 12(5):453&#x2013;7. doi:&#xa0;10.1038/nmeth.3337</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3337</ArticleId><ArticleId IdType="pmc">PMC4739640</ArticleId><ArticleId IdType="pubmed">25822800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics (2010) 26(12):1572&#x2013;3. doi:&#xa0;10.1093/bioinformatics/btq170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq170</ArticleId><ArticleId IdType="pmc">PMC2881355</ArticleId><ArticleId IdType="pubmed">20427518</ArticleId></ArticleIdList></Reference><Reference><Citation>Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. . Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol (2016) 17(1):218. doi:&#xa0;10.1186/s13059-016-1070-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-016-1070-5</ArticleId><ArticleId IdType="pmc">PMC5073889</ArticleId><ArticleId IdType="pubmed">27765066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr (2020) 16(1):19&#x2013;30. doi:&#xa0;10.1007/s12519-019-00229-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pmc">PMC7040062</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung WS, Lin CL, Chang SN, Lu CC, Kao CH. Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study. J Thromb Haemost (2014) 12(4):452&#x2013;8. doi:&#xa0;10.1111/jth.12518</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12518</ArticleId><ArticleId IdType="pubmed">24472157</ArticleId></ArticleIdList></Reference><Reference><Citation>Avina-Zubieta JA, Vostretsova K, De Vera MA, Sayre EC, Choi HK. The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: a general population-based study. Semin Arthritis Rheum (2015) 45(2):195&#x2013;201. doi:&#xa0;10.1016/j.semarthrit.2015.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2015.05.008</ArticleId><ArticleId IdType="pmc">PMC5479699</ArticleId><ArticleId IdType="pubmed">26364556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol (2008) 143(2):180&#x2013;90. doi:&#xa0;10.1111/j.1365-2141.2008.07323.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2008.07323.x</ArticleId><ArticleId IdType="pubmed">18783400</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley JH, Conway EM. Cross talk pathways between coagulation and inflammation. Circ Res (2016) 118(9):1392&#x2013;408. doi:&#xa0;10.1161/CIRCRESAHA.116.306853</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.306853</ArticleId><ArticleId IdType="pubmed">27126649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimaki T, Peltola J, et al. . Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum (2004) 50(3):858&#x2013;65. doi:&#xa0;10.1002/art.20045</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20045</ArticleId><ArticleId IdType="pubmed">15022328</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA. The interferon inducible gene: viperin. J Interferon Cytokine Res (2011) 31(1):131&#x2013;5. doi:&#xa0;10.1089/jir.2010.0127</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2010.0127</ArticleId><ArticleId IdType="pmc">PMC3021329</ArticleId><ArticleId IdType="pubmed">21142818</ArticleId></ArticleIdList></Reference><Reference><Citation>Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase b: a tuner and amplifier of immune functions. Trends Immunol (2001) 22(10):571&#x2013;9. doi:&#xa0;10.1016/s1471-4906(01)02023-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1471-4906(01)02023-3</ArticleId><ArticleId IdType="pubmed">11574282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawrin C, Brunn A, Rocken C, Schroder JM. Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases. Acta Neuropathol (2003) 105(4):365&#x2013;72. doi:&#xa0;10.1007/s00401-002-0653-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-002-0653-2</ArticleId><ArticleId IdType="pubmed">12624790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketha H, Singh RJ. Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1). Methods (2015) 81:93&#x2013;8. doi:&#xa0;10.1016/j.ymeth.2015.04.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2015.04.029</ArticleId><ArticleId IdType="pubmed">25937392</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths CD, Bilawchuk LM, McDonough JE, Jamieson KC, Elawar F, Cen Y, et al. . IGF1R is an entry receptor for respiratory syncytial virus. Nature (2020) 583(7817):615&#x2013;9. doi:&#xa0;10.1038/s41586-020-2369-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2369-7</ArticleId><ArticleId IdType="pubmed">32494007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Sun H, Ma B, Gao J, Yin J, Qu S. Insulin-like growth factor 1 related to chronic low-grade inflammation in patients with obesity and early change of its levels after laparoscopic sleeve gastrectomy. Obes Surg (2020) 30(9):3326&#x2013;32. doi:&#xa0;10.1007/s11695-020-04473-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-020-04473-9</ArticleId><ArticleId IdType="pubmed">32410151</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H, Mishra R, Yacoub N, Alanazi S, Kilroy MK, Garrett JT. IGF1R/IR mediates resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma. Cancers (Basel) (2021) 13(22):5863. doi:&#xa0;10.3390/cancers13225863</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13225863</ArticleId><ArticleId IdType="pmc">PMC8616282</ArticleId><ArticleId IdType="pubmed">34831014</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti E, Musumeci MB, De Giusti M, Dito E, Mastromarino V, Autore C, et al. . IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clin Sci (Lond) (2011) 120(9):377&#x2013;402. doi:&#xa0;10.1042/CS20100400</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20100400</ArticleId><ArticleId IdType="pubmed">21244364</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen SB, Cowley CJ, Sajjath SM, Barrows D, Yang Y, Carroll TS, et al. . Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell (2021) 28(10):1758&#x2013;1774 e8. doi:&#xa0;10.1016/j.stem.2021.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8500942</ArticleId><ArticleId IdType="pubmed">34320411</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzese CJ, Bliden KP, Gesheff MG, Pandya S, Guyer KE, Singla A, et al. . Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy. Am J Cardiol (2015) 115(9):1204&#x2013;11. doi:&#xa0;10.1016/j.amjcard.2015.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.02.002</ArticleId><ArticleId IdType="pubmed">25759102</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HJ, Kim JW, Cho BS, Chung JH. Association of FOS-like antigen 1 promoter polymorphism with podocyte foot process effacement in immunoglobulin a nephropathy patients. J Clin Lab Anal (2014) 28(5):391&#x2013;7. doi:&#xa0;10.1002/jcla.21699</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.21699</ArticleId><ArticleId IdType="pmc">PMC6807477</ArticleId><ArticleId IdType="pubmed">24652774</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu M, Wong CK, Cai Z, Dong J, Jiao D, Kam NW, et al. . Elevated expression and pro-inflammatory activity of IL-36 in patients with systemic lupus erythematosus. Molecules (2015) 20(10):19588&#x2013;604. doi:&#xa0;10.3390/molecules201019588</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules201019588</ArticleId><ArticleId IdType="pmc">PMC6332178</ArticleId><ArticleId IdType="pubmed">26516833</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CK, Kaplan MJ. The role of neutrophils in the pathogenesis of systemic lupus erythematosus. Curr Opin Rheumatol (2015) 27(5):448&#x2013;53. doi:&#xa0;10.1097/BOR.0000000000000197</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000197</ArticleId><ArticleId IdType="pubmed">26125102</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Kronbichler A, Park DD, Park Y, Moon H, Kim H, et al. . Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review. Autoimmun Rev (2017) 16(11):1160&#x2013;73. doi:&#xa0;10.1016/j.autrev.2017.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.09.012</ArticleId><ArticleId IdType="pubmed">28899799</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JY, Ho JH, Pasoto SG, Bunin V, Kim ST, Carrasco S, et al. . Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol (2015) 67(4):988&#x2013;99. doi:&#xa0;10.1002/art.39020</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39020</ArticleId><ArticleId IdType="pmc">PMC4450082</ArticleId><ArticleId IdType="pubmed">25581113</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorner T, Giesecke C, Lipsky PE. Mechanisms of b cell autoimmunity in SLE. Arthritis Res Ther (2011) 13(5):243. doi:&#xa0;10.1186/ar3433</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3433</ArticleId><ArticleId IdType="pmc">PMC3308063</ArticleId><ArticleId IdType="pubmed">22078750</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Q, Gong Z, Song H, Wang L, Yang F, Lv W, et al. . Symptomatic venous thromboembolism is a disease related to infection and immune dysfunction. Int J Med Sci (2012) 9(6):453&#x2013;61. doi:&#xa0;10.7150/ijms.4453</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.4453</ArticleId><ArticleId IdType="pmc">PMC3410365</ArticleId><ArticleId IdType="pubmed">22859906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Song H, Gong Z, Duan Q, Liang A. Acute pulmonary embolism and dysfunction of CD3+ CD8+ T cell immunity. Am J Respir Crit Care Med (2011) 184(11):1315. doi:&#xa0;10.1164/ajrccm.184.11.1315</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.184.11.1315</ArticleId><ArticleId IdType="pubmed">22162890</ArticleId></ArticleIdList></Reference><Reference><Citation>Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol (2010) 11(7):515&#x2013;28. doi:&#xa0;10.1038/nrm2918</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2918</ArticleId><ArticleId IdType="pubmed">20531426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura Y, Torigoe T, Kutomi G, Hirata K, Sato N. New paradigm for intrinsic function of heat shock proteins as endogenous ligands in inflammation and innate immunity. Curr Mol Med (2012) 12(9):1198&#x2013;206. doi:&#xa0;10.2174/156652412803306710</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652412803306710</ArticleId><ArticleId IdType="pubmed">22804242</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla HD, Pitha PM. Role of hsp90 in systemic lupus erythematosus and its clinical relevance. Autoimmune Dis (2012) 2012:728605. doi:&#xa0;10.1155/2012/728605</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/728605</ArticleId><ArticleId IdType="pmc">PMC3471389</ArticleId><ArticleId IdType="pubmed">23091704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Gu Y, Huang S, Lou Q, Xie Q, Xu Z, et al. . Copy number variations and polymorphisms in HSP90AB1 and risk of systemic lupus erythematosus and efficacy of glucocorticoids. J Cell Mol Med (2019) 23(8):5340&#x2013;8. doi:&#xa0;10.1111/jcmm.14410</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14410</ArticleId><ArticleId IdType="pmc">PMC6653051</ArticleId><ArticleId IdType="pubmed">31124601</ArticleId></ArticleIdList></Reference><Reference><Citation>Skvortsov SS, Gabdoulkhakova AG. Formyl peptide receptor polymorphisms: 27 most possible ways for phagocyte dysfunction. Biochem (Mosc) (2017) 82(4):426&#x2013;37. doi:&#xa0;10.1134/S0006297917040034</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297917040034</ArticleId><ArticleId IdType="pubmed">28371599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaffouli F, Hachicha H, Abida O, Gharbi N, Elloumi N, Kanoun H, et al. . Annexin A1 and its receptor gene polymorphisms in systemic lupus erythematosus in the Tunisian population. Clin Rheumatol (2022) 41(5):1359&#x2013;69. doi:&#xa0;10.1007/s10067-022-06057-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06057-7</ArticleId><ArticleId IdType="pubmed">35028743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubbers J, Brink M, van de Stadt LA, Vosslamber S, Wesseling JG, van Schaardenburg D, et al. . The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis (2013) 72(5):776&#x2013;80. doi:&#xa0;10.1136/annrheumdis-2012-202753</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-202753</ArticleId><ArticleId IdType="pubmed">23434571</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang JS, Lee JH, Jung NC, Choi SY, Park SY, Yoo JY, et al. . Rsad2 is necessary for mouse dendritic cell maturation via the IRF7-mediated signaling pathway. Cell Death Dis (2018) 9(8):823. doi:&#xa0;10.1038/s41419-018-0889-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0889-y</ArticleId><ArticleId IdType="pmc">PMC6070531</ArticleId><ArticleId IdType="pubmed">30068989</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, Zhao G, Ren D, Liu F, Dong G, Hou Y. Gender differences of b cell signature related to estrogen-induced IFI44L/BAFF in systemic lupus erythematosus. Immunol Lett (2017) 181:71&#x2013;8. doi:&#xa0;10.1016/j.imlet.2016.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2016.12.002</ArticleId><ArticleId IdType="pubmed">27923569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig RJ. Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4(+) T cells. Front Immunol (2017) 8:1992. doi:&#xa0;10.3389/fimmu.2017.01992</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01992</ArticleId><ArticleId IdType="pmc">PMC5776326</ArticleId><ArticleId IdType="pubmed">29387060</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>